CYDY

CytoDyn (QB) News

Best deals to access real time data!
Small Cap Basic
Monthly Subscription
for only
$33.03
Ultimate Trader (Monthly)
Monthly Subscription
for only
$80.29
DDE w/Realtime (Monthly)
Monthly Subscription
for only
$34.10
VAT not included
Company Name Stock Ticker Symbol Market Type
CytoDyn Inc (QB) CYDY OTCMarkets Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.135 -7.5% 1.665 16:00:06
Open Price Low Price High Price Close Price Prev Close
1.74 1.65 1.80 1.665 1.80
more quote information »

Recent News

Date Time Source Heading
7/22/202117:26EDGARCurrent Report Filing (8-k)
7/20/202117:06EDGARProxy Statement - Contested Solicitations (preliminary)..
7/20/202100:01SEEKCytoDyn to hold webcast on July 22 to discuss cancer, NASH,..
7/19/202106:19SEEKCytoDyn reports preliminary leronlimab results from..
7/12/202118:31EDGARInitial Statement of Beneficial Ownership (3)
7/12/202107:10SEEKCytoDyn advances leronlimab into Phase 2 stage in breast..
7/09/202117:12EDGARCurrent Report Filing (8-k)
7/07/202116:17EDGARAdditional Proxy Soliciting Materials - Non-management..
7/06/202116:31EDGARCurrent Report Filing (8-k)
7/06/202107:00IHNWCEO Presenting on the Emerging Growth / Investors Hub Joint..
7/02/202101:55SEEKCytoDyn submits dose justification report to FDA for..
7/01/202117:28EDGARAdditional Proxy Soliciting Materials - Non-management..
6/22/202109:55IHNWCLNV Targets $300 Billion Food Packaging Industry With..
6/22/202107:00IHNWCEO Presenting on the First Emerging Growth / Investors Hub..
6/21/202109:38SEEKCytoDyn posts preliminary results from COVID-19 long-haulers..
6/15/202117:01EDGARCurrent Report Filing (8-k)
6/08/202116:32EDGARAmended Statement of Beneficial Ownership (sc 13d/a)
6/08/202107:00IHNWCEO's Presenting at Emerging Growth Conference Virtually..
5/27/202106:33SEEKCytoDyn's partner to submit request to conduct Phase 3..
5/24/202117:16EDGARStatement of Beneficial Ownership (sc 13d)
5/20/202117:18EDGARCurrent Report Filing (8-k)
5/20/202117:14SEEKCytoDyn promotes Antonio Migliarese to CFO role
5/20/202109:43IHNWIQST Signals BUY
5/18/202107:45SEEKCytoDyn to submit CD12 trial data to regulatory agencies in..
5/17/202117:02EDGARCurrent Report Filing (8-k)
5/17/202115:51SEEKCytoDyn plunges as FDA rebukes its clinical trials for..
5/13/202109:04SEEKCytoDyn inks leronlimab distribution deal in India for..
5/10/202107:00IHNWCEO Presenting at Emerging Growth Conference Virtually This..
5/05/202106:25SEEKCytoDyn to conduct two COVID-19 trials in Brazil
5/03/202109:46SEEKCytoDyn provides updates on leronlimab HIV extension arm; to..
4/29/202116:32EDGARCurrent Report Filing (8-k)
4/21/202118:28EDGARStatement of Changes in Beneficial Ownership (4)
4/21/202116:31EDGARCurrent Report Filing (8-k)
4/19/202106:54SEEKCytoDyn initiates rolling submission of leronlimab in..
4/15/202109:34SEEKCytoDyn executes supply and distribution agreement with..
4/12/202116:31EDGARCurrent Report Filing (8-k)
4/09/202106:59SEEKCytoDyn completes enrollment in COVID-19 long-hauler trial
4/05/202111:51SEEKCytoDyn updates on leronlimab-treated COVID-19 patient
4/01/202106:19SEEKCytoDyn to provide full update on its activities on April 6
4/01/202106:13SEEKCytoDyn files new protocol with FDA for 4 doses of..
3/30/202107:08SEEKCytoDyn’s leronlimab reduces mortality by 82% at 14 days in..
3/29/202106:30SEEKPhilippines OKs use of CytoDyn's leronlimab in COVID-19
3/24/202106:45IHNWNextech AR (OTCQB: NEXCF) Doubling Sales - Emerging Growth..
3/18/202119:46EDGARInitial Statement of Beneficial Ownership (3)
3/16/202108:31EDGARCurrent Report Filing (8-k)
3/16/202106:03SEEKCytoDyn promotes from within for COO role
3/11/202107:53IHNWNextech AR (OTCQB: NEXCF) $13 million Deal, The Next Short..
3/11/202105:49SEEKEnrollment underway in CytoDyn’s long-haulers COVID-19 trial
3/08/202117:28EDGARCurrent Report Filing (8-k)
3/08/202106:34SEEKCytoDyn to release CD12 trial data on March 8
See more news about this stock »


Your Recent History
USOTC
CYDY
CytoDyn (Q..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.